by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersOrderlyMeds LLC dba OrderlyMeds

All Warning Letters

OrderlyMeds LLC dba OrderlyMeds

Warning LetterOpen

Recipient Name Brian Spears, MD, 235 Ponce De Leon Pl., Suite M347 Decatur , GA 30030 United StatesIssued Jun 8, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateJun 8, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: OrderlyMeds LLC dba OrderlyMeds
Location: Recipient Name Brian Spears, MD, 235 Ponce De Leon Pl., Suite M347 Decatur , GA 30030 United States
FEI Number: N/A
Country: United States
Issue Date: June 08, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

False & Misleading Claims/Misbranded (Telehealth)

OrderlyMeds LLC dba OrderlyMeds FDA Warning Letter, June 8, 2026